Cartesian Therapeutics Inc. (RNAC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.35
• Market Cap: $205.17M
• EPS: $-1.33
• 52-Week High: $18.97
• 52-Week Low: $5.98

Market Sentiment

Cartesian Therapeutics Inc. currently has a Bullish sentiment score of 0.17.

About Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc. (ticker: RNAC) is a leading clinical-stage biopharmaceutical company based in Watertown, Massachusetts, specializing in the development of breakthrough nanoparticle immunomodulatory therapeutics. The company is at the forefront of addressing critical unmet medical needs through its innovative drug platform, which aims to enhance immune responses across various therapeutic areas. With a diverse pipeline of advanced biotherapeutics currently under clinical evaluation...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cartesian Therapeutics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RNAC pay dividends?

Cartesian Therapeutics Inc. (RNAC) does not currently pay a regular dividend.

What is RNAC's market cap?

Cartesian Therapeutics Inc. (RNAC) has a market capitalization of $205.17M with a current stock price of $8.35.